Clinical characterization of children and adolescents with NF1 microdeletions
- PDF / 469,127 Bytes
- 14 Pages / 595.276 x 790.866 pts Page_size
- 27 Downloads / 216 Views
ANNUAL ISSUE PAPER
Clinical characterization of children and adolescents with NF1 microdeletions Hildegard Kehrer-Sawatzki 1 & Lan Kluwe 2,3 & Johannes Salamon 4 & Lennart Well 4 & Said Farschtschi 3 & Thorsten Rosenbaum 5 & Victor-Felix Mautner 3 Received: 15 May 2020 / Accepted: 28 May 2020 # The Author(s) 2020
Abstract Purpose An estimated 5–11% of patients with neurofibromatosis type 1 (NF1) harbour NF1 microdeletions encompassing the NF1 gene and its flanking regions. The purpose of this study was to evaluate the clinical phenotype in children and adolescents with NF1 microdeletions. Methods We retrospectively analysed 30 children and adolescents with NF1 microdeletions pertaining to externally visible neurofibromas. The internal tumour load was determined by volumetry of whole-body magnetic resonance imaging (MRI) in 20 children and adolescents with NF1 microdeletions. Furthermore, the prevalence of global developmental delay, autism spectrum disorder and attention deficit hyperactivity disorder (ADHD) were evaluated. Results Children and adolescents with NF1 microdeletions had significantly more often cutaneous, subcutaneous and externally visible plexiform neurofibromas than age-matched patients with intragenic NF1 mutations. Internal neurofibromas were detected in all 20 children and adolescents with NF1 microdeletions analysed by whole-body MRI. By contrast, only 17 (61%) of 28 agematched NF1 patients without microdeletions had internal tumours. The total internal tumour load was significantly higher in NF1 microdeletion patients than in NF1 patients without microdeletions. Global developmental delay was observed in 28 (93%) of 30 children with NF1 microdeletions investigated. The mean full-scale intelligence quotient in our patient group was 77.7 which is significantly lower than that of patients with intragenic NF1 mutations. ADHD was diagnosed in 15 (88%) of 17 children and adolescents with NF1 microdeletion. Furthermore, 17 (71%) of the 24 patients investigated had T-scores ≥ 60 up to 75, indicative of mild to moderate autistic symptoms, which are consequently significantly more frequent in patients with NF1 microdeletions than in the general NF1 population. Also, the mean total T-score was significantly higher in patients with NF1 microdeletions than in the general NF1 population. Conclusion Our findings indicate that already at a very young age, NF1 microdeletions patients frequently exhibit a severe disease manifestation which requires specialized long-term clinical care. Keywords Neurofibromatosis type 1 . NF1 microdeletion . Autism spectrum disorder . Cognitive impairment . Neurofibroma . Attention deficit hyperactivity disorder (ADHD)
Electronic supplementary material The online version of this article (https://doi.org/10.1007/s00381-020-04717-0) contains supplementary material, which is available to authorized users. * Hildegard Kehrer-Sawatzki [email protected] 1
Institute of Human Genetics, University of Ulm and University of Ulm Medical Center, Albert-Einstein-Allee 11
Data Loading...
